LCG
TNDM icon

Lisanti Capital Growth’s Tandem Diabetes Care TNDM Stock Holding History

Lisanti Capital Growth’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-165,325
Closed -$3.17M – 146
2026
Q1 		$3.17M Sell
165,325
-97,560
-37% -$2.12M 0.8% 55
2025
Q4 		$5.78M Buy
+262,885
New +$4.74M 1.37% 20
2025
Q3 		– Sell
-253,840
Closed -$4.73M – 138
2025
Q2 		$4.73M Buy
+253,840
New +$5.03M 1.31% 30
2025
Q1 		– Sell
-118,550
Closed -$4.27M – 158
2024
Q4 		$4.27M Buy
118,550
+3,625
+3% +$123K 1.03% 39
2024
Q3 		$4.87M Sell
114,925
-43,335
-27% -$1.84M 1.23% 29
2024
Q2 		$6.38M Sell
158,260
-16,570
-9% -$691K 1.53% 15
2024
Q1 		$6.19M Buy
174,830
+68,935
+65% +$1.85M 1.51% 12
2023
Q4 		$3.13M Buy
+105,895
New +$2.2M 0.74% 63
2022
Q3 		– Sell
-43,572
Closed -$2.58M – 137
2022
Q2 		$2.58M Sell
43,572
-81,082
-65% -$6.66M 0.35% 87
2022
Q1 		$14.5M Buy
124,654
+49,154
+65% +$5.74M 1.63% 13
2021
Q4 		$11.4M Buy
75,500
+22,600
+43% +$3.05M 1.64% 10
2021
Q3 		$6.32M Buy
52,900
+11,580
+28% +$1.28M 0.93% 38
2021
Q2 		$4.03M Buy
+41,320
New +$3.68M 0.5% 82
2020
Q4 		– Sell
-100,345
Closed -$11.4M – 147
2020
Q3 		$11.4M Buy
100,345
+41,402
+70% +$4.35M 2.11% 3
2020
Q2 		$5.83M Sell
58,943
-31,138
-35% -$2.48M 1.19% 26
2020
Q1 		$5.8M Buy
90,081
+26,314
+41% +$1.84M 1.91% 8
2019
Q4 		$3.8M Sell
63,767
-23,668
-27% -$1.46M 1.01% 40
2019
Q3 		$5.16M Sell
87,435
-10,890
-11% -$695K 1.68% 21
2019
Q2 		$6.34M Buy
98,325
+51,070
+108% +$3.3M 2.06% 9
2019
Q1 		$3M Sell
47,255
-13,850
-23% -$728K 1.06% 36
2018
Q4 		$2.32M Buy
61,105
+24,130
+65% +$852K 0.94% 50
2018
Q3 		$1.58M Buy
+36,975
New +$1.29M 0.55% 76
2014
Q1 		– Sell
-1,943
Closed -$501K – 124
2013
Q4 		$501K Buy
+1,943
New +$444K 0.21% 100

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Lisanti Capital Growth's TNDM Position: Q2 2026 in Review

Lisanti Capital Growth sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 165,325 shares — an estimated $3.17M sold.

Lisanti Capital Growth first reported a position in TNDM in Q4 2013 and held it in 23 quarters. The position peaked at $14.5M in Q1 2022. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Lisanti Capital Growth reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • Lisanti Capital Growth sold 165,325 Tandem Diabetes Care shares in Q2 2026, an estimated $3.17M.
  • Lisanti Capital Growth first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 23 quarters.
  • Lisanti Capital Growth's Tandem Diabetes Care position peaked at $14.5M in Q1 2022.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Lisanti Capital Growth's 13F filing for Q2 2026, filed 10 Aug 2026.